Virtual Scientific Meeting 2021

Past Meetings


This two day virtual scientific meeting was held on 20th April and 27th May, 2021. Delegates connected to discuss key issues in the field of reproductive toxicology, teratology, pregnancy pharmacovigilance and medication use risk-benefit communication.



Meeting Details

  • The virtual meeting was open to ENTIS and non-ENTIS member
  • There was an accompanying online poster walk accessible online (posters can still be viewed in the members area)

Scientific Programme

Tuesday 20th April 16:00-18:00 CEST

Keynote lecture by Prof. Sonia Rasmussen (USA) – Guidelines and clinical recommendations on the use of COVID-19 vaccines during pregnancy and breastfeeding

5 oral presentations:

o Update on the risk of VITT  following viral vector vaccine exposure and the implications for pregnant women (Ken Hodson)
o Pregnancy outcome after first trimester exposure to duloxetine (Svetlana Schechtman)
o SSRIs and SNRIs during pregnancy and the risk for ASD and ADHD in the offspring: a true effect or a bias? A systematic review & meta-analysis (Regina Leshem)
o Artificial Intelligence – game changer in the Teratology Information Service (Guy Shtar)
o Pregnancy outcome following first trimester exposure to naproxen: a collaborative case series from TIS Berlin and Ulm (Stefanie Hultzsch)

Thursday 27th May 16:00-18:00 CEST

5 oral presentations:

o Maternal valacyclovir treatment in fetal CMV infection from amniocentesis until delivery: maternal & neonatal outcome (Carmen De Luca)
 o A project to improve data quality on congenital disorders after maternal medication during pregnancy – extending the follow-up period to two years (Corinna Weber-Schöndorfer) 
o Pattern of malformations after methimazole or propylthiouracil exposure in early pregnancy: a meta-analytic approach (Cyndie Picot) 
o Risk of gestational diabetes mellitus after use of antidepressant medication in pregnancy: results from the Norwegian Mother and Child Cohort Study (Angela Lupattelli) 
o Is the use of direct oral anticoagulants safe during pregnancy? (Wolfgang Paulus)

Presentation and open discussion on ENTIS sustainability and development opportunities (moderator: Brian Cleary)